查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2046128

流式細胞技術市場－全球產業規模、佔有率、趨勢、機會和預測：按技術、產品/服務、應用、最終用戶、地區和競爭格局分類，2021-2031年

Flow Cytometry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Product & Service, By Application, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 192 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球流式細胞技術市場預計將從 2025 年的 53.2 億美元大幅成長至 2031 年的 82.5 億美元，複合年成長率為 7.59%。

這一成長主要受免疫不全症和癌症發病率上升的驅動，這些疾病和癌症需要精確的診斷和監測工具。流式細胞技術是一種基於雷射的技術，它分析流動路徑中細胞的物理和化學特性，對於應對日益成長的患者負擔至關重要。美國癌症協會估計，到2025年，美國新增癌症病例將達到2,041,910例。此外，對藥物研發和幹細胞研究的大力投入也催生了對先進的高通量篩檢方法的需求，進一步推動了市場擴張。儘管成長前景可觀，但該市場仍面臨許多挑戰，主要原因是流式細胞技術設備的安裝和維護高成本。這些設備的巨額資本投入，加上持續的試劑成本以及對專業人員的需求，限制了其在小規模實驗室和醫療機構（尤其是在發展中地區）的應用。這些經濟障礙可能會阻礙流式細胞技術技術的廣泛應用，並抑制其在成本敏感市場的擴張。

市場概覽
預測期 2027-2031
市場規模：2025年 53.2億美元
市場規模：2031年 82.5億美元
複合年成長率：2026-2031年 7.59%
成長最快的細分市場 臨床診斷
最大的市場 北美洲

市場促進因素

流式細胞技術平台的技術進步是推動市場成長的主要動力，尤其是光譜分析和高速成像的創新。這些改進使研究人員能夠以更高的靈敏度識別複雜的細胞亞群，從而克服了傳統螢光補償的挑戰。貝克曼庫爾特生命科學公司於2025年3月推出的CytoFLEX馬賽克光譜檢測模組就是一個顯著的例子。該模組支援高參數分析，並將先進的頻譜解混技術整合到實驗室工作流程中，從而簡化了高維生物學的操作，並最大限度地從有限的樣本中資料提取。這一快速的技術進步得到了該行業的大力投資支持，例如，貝克頓·迪金森公司在2025年第四季度投入3.22億美元用於研發。此外，免疫療法和幹細胞研究領域應用的不斷擴展也顯著推動了市場成長，尤其是嵌合體抗原受體（CAR）T細胞療法的快速發展。流式細胞技術對於監測T細胞的持久性、評估療效以及確保CAR-T療法整個生產過程中的嚴格品管至關重要。根據2025年5月發表於《免疫學前沿》（Frontiers in Immunology）的報告，截至2024年4月，全球已開展約1580項CAR-T臨床試驗，顯示臨床需求極為旺盛。隨著這些細胞療法開發平臺拓展至固體癌和自體免疫疾病領域，對用於精準免疫分析和病患監測的先進流式細胞技術解決方案的需求日益成長，這將鞏固該技術在未來精準醫療中的關鍵作用。

市場挑戰

流式細胞技術設備所需的大量資本投入是市場成長的主要障礙，尤其是在資源有限的環境中。高昂的初始投資成本，加上試劑、維護和專業培訓等持續支出，大大限制了小規模實驗室和學術機構的採用能力。這種經濟負擔往往迫使醫療機構延長現有設備的使用壽命，而不是投資更新、更有效率的系統，導致設備升級週期延長，並阻礙了整體市場發展動能。這種經濟壓力在近期的採購趨勢中得到了清晰的體現，預算限制直接影響了採購決策。美國醫院協會 (AHA) 在 2025 年報告中指出，94% 的醫療機構管理者預計將推遲設備升級以緩解財務壓力。這種資本投資的延遲將導致新設備的銷售下降，並限制其在成本敏感地區的市場滲透。由於檢查室優先考慮必要的營運成本而非昂貴的資本投資，先進流式細胞技術解決方案的廣泛應用仍面臨許多挑戰。

市場趨勢

人工智慧 (AI) 和機器學習 (ML) 與數據分析的融合正在變革流式細胞技術市場，有效管理複雜的高維度資料集。由於流式細胞技術方案如今涵蓋大量參數，傳統的手動設門效率低且易受人為因素影響。這導致人們對利用 AI 驅動演算法精確識別細胞群的需求日益成長。這些先進的計算工具不僅規範了分析流程，還支援創新的無標定表徵技術，有效將資料複雜性與試劑限制解耦。例如，SelectScience 於 2025 年 1 月報導了 Labtools.AI，這是一個利用 AI 技術生成每個細胞多達 1000 種蛋白質表現圖譜的新平台，無需傳統的抗體標記，從而顯著加速了生物標記的發現。同時，樣品製備的自動化和工作流程的標準化正成為消除手動操作瓶頸的關鍵趨勢。實驗室正擴大採用機器人系統來減少人為錯誤，確保大規模研究中數據的可重複性，並提高操作效率。這種轉變在藥物研發和臨床試驗中尤其關鍵，因為數據一致性至關重要，時間也至關重要。 2025年2月，《技術網路》雜誌重點報導了Bio-Rad公司的ZE5細胞分析儀，該分析儀能夠透過自動化工作流程在不到一小時內處理384個檢體，凸顯了行業正迅速向快速、無需人工干預的操作模式轉變，以滿足日益成長的診斷和研究需求。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球流式細胞技術市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術分類（基於細胞、以微珠為基礎）
    • 依產品/服務分類（設備、試劑/耗材、軟體、服務）
    • 按應用領域（調查、臨床診斷、產業）
    • 按最終用戶（製藥和生物技術公司、學術和研究機構、醫院和臨床檢查室、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美流式細胞技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲流式細胞技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區流式細胞技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲流式細胞技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲流式細胞技術市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球流式細胞技術市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Becton, Dickinson and Company
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Sysmex Corporation
  • Merck KGaA
  • bioMerieux SA
  • Enzo Life Sciences Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27622

The global flow cytometry market is projected to expand significantly, from USD 5.32 billion in 2025 to USD 8.25 billion by 2031, demonstrating a compound annual growth rate of 7.59%. This growth is primarily fueled by the increasing incidence of immunodeficiency disorders and cancer, which demand precise diagnostic and monitoring tools. Flow cytometry, a laser-based technique for analyzing cellular physical and chemical properties in a fluid stream, is crucial for addressing the rising patient burden, with the American Cancer Society estimating 2,041,910 new cancer cases in the United States in 2025. Additionally, robust investments in pharmaceutical drug discovery and stem cell research further propel market expansion by requiring advanced high-throughput screening methods. Despite this promising growth trajectory, the market faces considerable challenges, mainly due to the high costs associated with acquiring and maintaining flow cytometry instrumentation. The substantial capital expenditure for these devices, coupled with ongoing expenses for reagents and the need for specialized personnel, limits access for smaller laboratories and healthcare facilities, particularly in developing regions. These financial barriers hinder the widespread adoption of flow cytometry technology and could impede its expansion into more cost-sensitive markets.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.32 Billion
Market Size 2031USD 8.25 Billion
CAGR 2026-20317.59%
Fastest Growing SegmentClinical Diagnostics
Largest MarketNorth America

Market Driver

Technological advancements in flow cytometry platforms are a primary growth catalyst, particularly through innovations in spectral analysis and high-speed imaging. These enhancements allow researchers to identify complex cellular subsets with superior sensitivity, mitigating traditional fluorescence compensation challenges. A notable example is Beckman Coulter Life Sciences' March 2025 launch of the CytoFLEX mosaic Spectral Detection Module, which enables high-parameter analysis and integrates advanced spectral unmixing into laboratory workflows, thereby streamlining high-dimensional biology operations and maximizing data extraction from limited samples. This swift technological progress is underpinned by significant industry investments, exemplified by Becton, Dickinson and Company's $322 million allocation to research and development in Q4 2025. Furthermore, the expanding applications in immunotherapy and stem cell research significantly drive the market, especially with the proliferation of Chimeric Antigen Receptor (CAR) T-cell therapies. Flow cytometry is essential for monitoring T-cell persistence, evaluating potency, and ensuring stringent quality control throughout the CAR-T therapeutic manufacturing process. The clinical demand is substantial, with nearly 1,580 registered CAR-T clinical trials globally as of April 2024, as reported by Frontiers in Immunology in May 2025. As the development pipeline for these cell-based therapies extends to solid tumors and autoimmune diseases, the increasing need for advanced cytometry solutions for precise immune profiling and patient monitoring will solidify the technology's critical role in future precision medicine.

Market Challenge

The significant capital investment necessary for flow cytometry instrumentation presents a substantial barrier to market growth, particularly in resource-constrained environments. High initial acquisition costs, combined with ongoing expenditures for reagents, maintenance, and specialized training, severely limit the adoption capacity of smaller laboratories and academic institutions. This financial burden often compels healthcare facilities to prolong the lifespan of their current equipment rather than acquiring newer, more efficient systems, thereby slowing down the equipment replacement cycle and hindering overall market momentum. This economic strain is clearly reflected in recent procurement trends, where budgetary limitations directly influence purchasing decisions. The American Hospital Association reported in 2025 that 94% of healthcare administrators anticipated postponing equipment upgrades to mitigate financial pressures. Such deferrals in capital expenditure consequently diminish new unit sales and restrict market penetration into cost-sensitive regions. As laboratories prioritize essential operational costs over expensive capital upgrades, the broad adoption of advanced flow cytometry solutions continues to face significant impediments.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) in data analysis is profoundly transforming the flow cytometry market by effectively managing complex high-dimensional datasets. With flow cytometry panels now encompassing numerous parameters, conventional manual gating has become inefficient and susceptible to user bias, thus driving the demand for AI-driven algorithms to accurately identify cell populations. These sophisticated computational tools not only standardize analytical processes but also enable innovative label-free characterization techniques, effectively separating data complexity from reagent constraints. For example, SelectScience reported in January 2025 on Labtools.AI's new platform, which uses AI to generate digital expression profiles for up to 1,000 proteins per cell without traditional antibody labeling, thereby significantly accelerating biomarker discovery. Simultaneously, the automation of sample preparation and workflow standardization is emerging as a crucial trend to alleviate bottlenecks associated with manual procedures. Laboratories are increasingly adopting robotic systems to reduce human error, ensure data reproducibility in large-scale studies, and boost operational throughput. This transition is especially important in pharmaceutical drug discovery and clinical trials, where data consistency is critical and time is of the essence. Technology Networks highlighted in February 2025 that Bio-Rad's ZE5 Cell Analyzer can process 384 samples in less than an hour through automated workflows, underscoring the industry's swift move towards high-speed, hands-free operations to meet growing diagnostic and research requirements.

Key Market Players

  • Becton, Dickinson and Company
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • Luminex Corporation
  • Sysmex Corporation
  • Merck KGaA
  • bioMerieux SA
  • Enzo Life Sciences Inc.

Report Scope

In this report, the Global Flow Cytometry Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Flow Cytometry Market, By Technology

  • Cell-based
  • Bead-based

Flow Cytometry Market, By Product & Service

  • Instruments
  • Reagents & Consumables
  • Software
  • Services

Flow Cytometry Market, By Application

  • Research
  • Clinical Diagnostics
  • Industrial

Flow Cytometry Market, By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Clinical Testing Labs
  • Others

Flow Cytometry Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Flow Cytometry Market.

Available Customizations:

Global Flow Cytometry Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Flow Cytometry Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Cell-based, Bead-based)
    • 5.2.2. By Product & Service (Instruments, Reagents & Consumables, Software, Services)
    • 5.2.3. By Application (Research, Clinical Diagnostics, Industrial)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Clinical Testing Labs, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Flow Cytometry Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Product & Service
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Flow Cytometry Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Product & Service
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Flow Cytometry Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Product & Service
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Flow Cytometry Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Product & Service
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Flow Cytometry Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Product & Service
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Flow Cytometry Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Product & Service
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. France Flow Cytometry Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Product & Service
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom Flow Cytometry Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Product & Service
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy Flow Cytometry Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Product & Service
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Flow Cytometry Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Product & Service
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia Pacific Flow Cytometry Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product & Service
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Flow Cytometry Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Product & Service
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Flow Cytometry Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Product & Service
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Flow Cytometry Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Product & Service
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Flow Cytometry Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Product & Service
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Flow Cytometry Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Product & Service
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. Middle East & Africa Flow Cytometry Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product & Service
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Flow Cytometry Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Product & Service
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. UAE Flow Cytometry Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Product & Service
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. South Africa Flow Cytometry Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Product & Service
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. South America Flow Cytometry Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product & Service
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Flow Cytometry Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Product & Service
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Colombia Flow Cytometry Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Product & Service
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. Argentina Flow Cytometry Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Product & Service
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Flow Cytometry Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Becton, Dickinson and Company
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Agilent Technologies Inc.
  • 15.5. Bio-Rad Laboratories Inc.
  • 15.6. Luminex Corporation
  • 15.7. Sysmex Corporation
  • 15.8. Merck KGaA
  • 15.9. bioMerieux SA
  • 15.10. Enzo Life Sciences Inc.

16. Strategic Recommendations

17. About Us & Disclaimer